$5.50
-0.23-4.01%
At close: -
$5.70
0.203.64%
After Hours: 4:19 PM EDT
Comments
Loading...
Emergent BioSolutions Earnings Estimates, EPS & Revenue | NYSE:EBS | Benzinga
Emergent BioSolutions reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 3
EPS
$0.050
Quarterly Revenue
$194.70M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.01B
Analyze the earnings history of Emergent BioSolutions using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions | $0.59 | — | — | — | $300.40M | — | — | — | 04/30/2025 | Get Alert |
| EBS | Emergent BioSolutions | -$0.77 | -$0.50 | $0.05 | 110.00% | $276.60M | $254.67M | $194.70M | -23.55% | 03/03/2025 | Get Alert |
| EBS | Emergent BioSolutions | -$1.09 | $0.14 | $1.37 | 878.57% | $270.50M | $297.50M | $293.80M | -1.24% | 11/06/2024 | Get Alert |
| EBS | Emergent BioSolutions | -$1.06 | -$0.94 | -$2.32 | -146.81% | $337.90M | $190.00M | $254.70M | 34.05% | 08/06/2024 | Get Alert |
| EBS | Emergent BioSolutions | -$3.26 | -$0.83 | $0.59 | 171.08% | $164.30M | $224.50M | $300.40M | 33.81% | 05/01/2024 | Get Alert |
| EBS | Emergent BioSolutions | -$0.31 | -$0.19 | -$0.77 | -305.26% | $330.70M | $293.53M | $276.60M | -5.77% | 03/06/2024 | Get Alert |
| EBS | Emergent BioSolutions | -$1.27 | -$0.22 | -$0.87 | -295.45% | $240.00M | $237.43M | $270.50M | 13.93% | 11/08/2023 | Get Alert |
| EBS | Emergent BioSolutions | -$0.86 | -$0.47 | -$1.06 | -125.53% | $242.70M | $217.03M | $337.90M | 55.69% | 08/08/2023 | Get Alert |
| EBS | Emergent BioSolutions | $0.18 | -$1.24 | -$3.17 | -155.65% | $307.50M | $143.28M | $165.10M | 15.23% | 05/09/2023 | Get Alert |
| EBS | Emergent BioSolutions | $4.50 | $0.04 | -$0.31 | -875.00% | $723.20M | $296.62M | $330.70M | 11.49% | 02/27/2023 | Get Alert |
| EBS | Emergent BioSolutions | -$0.36 | -$0.06 | -$1.27 | -2016.67% | $329.00M | $268.30M | $240.00M | -10.55% | 11/08/2022 | Get Alert |
| EBS | Emergent BioSolutions | $0.33 | $0.37 | -$0.86 | -332.43% | $397.50M | $270.94M | $242.70M | -10.42% | 08/01/2022 | Get Alert |
| EBS | Emergent BioSolutions | $1.53 | $0.12 | $0.18 | 50.00% | $343.00M | $283.00M | $307.50M | 8.66% | 04/28/2022 | Get Alert |
| EBS | Emergent BioSolutions | $3.67 | $4.27 | $4.50 | 5.39% | $583.00M | $691.36M | $723.20M | 4.61% | 02/24/2022 | Get Alert |
| EBS | Emergent BioSolutions | $2.19 | $2.35 | -$0.36 | -115.32% | $385.20M | $486.84M | $329.00M | -32.42% | 11/04/2021 | Get Alert |
| EBS | Emergent BioSolutions | $1.98 | $1.54 | $0.33 | -78.57% | $394.70M | $398.93M | $397.50M | -0.36% | 07/29/2021 | Get Alert |
| EBS | Emergent BioSolutions | $0.01 | $1.12 | $1.53 | 36.61% | $192.50M | $358.47M | $343.00M | -4.32% | 04/29/2021 | Get Alert |
| EBS | Emergent BioSolutions | $1.57 | $3.19 | $3.67 | 15.05% | $360.40M | $563.60M | $583.00M | 3.44% | 02/18/2021 | Get Alert |
| EBS | Emergent BioSolutions | $1.21 | $2.12 | $2.19 | 3.30% | $311.80M | $437.93M | $385.20M | -12.04% | 11/05/2020 | Get Alert |
| EBS | Emergent BioSolutions | -$0.12 | $0.64 | $1.98 | 209.38% | $243.20M | $294.73M | $394.70M | 33.92% | 07/30/2020 | Get Alert |
| EBS | Emergent BioSolutions | -$0.13 | $0.01 | $0.01 | 0.00% | $190.60M | $199.47M | $192.50M | -3.49% | 04/30/2020 | Get Alert |
Emergent BioSolutions (EBS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $0.05 | $-0.50 | 110.0 % |
| Q3 | 2024-11-06 | $1.37 | $0.14 | 878.6 % |
| Q2 | 2024-08-06 | $-2.32 | $-0.94 | -146.8 % |
| Q1 | 2024-05-01 | $0.59 | $-0.83 | 171.1 % |
Emergent BioSolutions (EBS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-03 | $194.70M | $254.67M | -23.5 % |
| Q3 | 2024-11-06 | $293.80M | $297.50M | -1.24 % |
| Q2 | 2024-08-06 | $254.70M | $190.00M | 34.1 % |
| Q1 | 2024-05-01 | $300.40M | $224.50M | 33.8 % |
FAQ
When is Emergent BioSolutions (NYSE:EBS) reporting earnings?
Emergent BioSolutions (EBS) is scheduled to report earnings on April 30, 2025. The last reported earnings were for reported on March 3, 2025 for Q4.
What were the latest earnings per share (EPS) for Emergent BioSolutions (NYSE:EBS)?
The Actual EPS was $0.05, which beat the estimate of $-0.50.
What were Emergent BioSolutions’s (NYSE:EBS) revenues?
The Actual Revenue was $194.7M, which missed the estimate of $254.7M.
Browse earnings estimates, EPS, and revenue on all stocks.